Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Thermo Electron Acquires Laboratory Services Provider LMSi

By Pharmaceutical Processing | November 5, 2003

Thermo Electron Corporation (NYSE:TMO), a leading global supplier of laboratory instruments and services, announced today that it has acquired Laboratory Management Systems, Inc. (LMSi) of New Castle, Delaware. LMSi is a supplier of regulatory instrument and consulting services to the pharmaceutical and related industries, and generated revenues of $11 million during its 2003 fiscal year. In its nine-year history, LMSi has been ranked three times on Inc. magazine’s annual “Inc. 500” list of America’s fastest-growing private companies.

LMSi specializes in performing instrument and computer systems validation,metrology, and certification, as well as a range of associated consultingservices. The company has developed a broad portfolio of analytical instrument validation protocols and operating procedures that enable laboratories to comply with U.S. Food and Drug Administration requirements.

“This acquisition is an important step in our strategy to offercustomers comprehensive laboratory solutions that include full product support,for almost any instrument, anywhere,” said Marijn E. Dekkers, president andchief executive officer of Thermo Electron. “Adding LMSi’s regulatoryand compliance expertise to our global laboratory service network will allowus to be a regulatory validation and consulting partner to customers whoface increasing productivity, quality, and regulatory challenges.”

Chuck Whitney, a founder of LMSi, remarked, “Combining LMSi’s expertisewith Thermo’s global resources and extensive line of products and servicessignificantly benefits our mutual customers, who are some of the leadingnames in the pharmaceutical industry. Thermo is uniquely positioned tooffer customers unparalleled product breadth and the security of partneringwith a well-recognized global services provider.”

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE